People Who Take Statins Are More Likely To Survive Cancer, A Study Suggests

32

PEOPLE who take statins are more likely to survive cancer, a study suggests.

Scientists say the cholesterol-busting pills boosted the effects of a drug used to treat leukaemia.

Getty – Contributor Statin tablets – taken by 5million Brits – may fight leukaemia and other types of blood cancer

And they believe the tablets – taken by 5million Brits – may also fight other types of blood cancer.

The boffins found combining statins with venetoclax made diseased cells in mice more likely to die.

This prompted them to review existing data on 338 leukaemia patients treated with the drug.

Analysis revealed those taking 4p-a-day statins had significantly better outcomes.

Getty – Contributor The way the statins and venetoclax interact means they may be beneficial for patients with lymphoma or myeloma

They typically lived longer without the disease getting worse.

And the statin patients were 2.7-times more likely to experience complete remission.

There were no differences in side-effects between the two groups.

The University of California researchers now want to carry out further trials to confirm their findings.

Professor David Fruman said: “It’s exciting to see that a cheap drug that is taken by millions of people and widely tolerated could help some cancer patients live longer.

“Our findings are only based on a retrospective review, so we now need to carry out prospective trials to see if we get the same results.

“The way the statins and venetoclax interact means they may be beneficial for patients with lymphoma or myeloma too.

“It is too early to suggest that people start taking statins for their potential cancer-fighting properties at this stage.”

Deborah James appears on The Wright Stuff to raise bowel cancer awareness and promote The Sun’s No Time 2 Lose campaign




Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.